Blocking autophagy with chloroquine aggravates lipid accumulation and reduces intracellular energy synthesis in hepatocellular carcinoma cells, both contributing to its anti-proliferative effect.


Journal

Journal of cancer research and clinical oncology
ISSN: 1432-1335
Titre abrégé: J Cancer Res Clin Oncol
Pays: Germany
ID NLM: 7902060

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 10 01 2022
accepted: 16 05 2022
pubmed: 14 6 2022
medline: 26 10 2022
entrez: 13 6 2022
Statut: ppublish

Résumé

The autophagy inhibitor chloroquine enhances the effect of targeted therapy using tyrosine kinase inhibitor in liver cancer. We would like to further understand the specific mechanism by which chloroquine inhibits the proliferation of tumor cells. We used a human hepatocarcinoma cell line (HepG2) as cell culture model. In contrast to the control groups (treated only with complete medium), cells in experimental groups were treated either with complete medium + 40 ng/ml Hepatocyte growth factor (HGF), or with complete medium + 60 μM chloroquine or with complete medium + 40 ng/ml HGF + 60 μM chloroquine for 24 h. Cell number and ATP content were investigated using spectrophotometric assays. Cell proliferation and apoptosis were detected by immunohistochemistry. Cell morphological alterations were examined by Giemsa and H&E staining. Cellular lipid content was determined by Oil Red O staining and Triglyceride quantification assay. Autophagy-related proteins (LC3B and p62) and hepatocyte proliferation-related protein (S6K1) were examined using western blot. The autophagic flux of cells was assessed by mRFP-EGFP-LC3 transfection assay. We found that chloroquine inhibited the proliferation of HepG2 cells, as evidenced by a decrease in cellular ATP content, Ki-67 and S6K1 protein expression and a reduction in cell number. This finding was associated with an increase in lipid content. As expected, chloroquine inhibited autophagy of HepG2 cells, as evidenced by the accumulation of LC3B-II and the significant upregulation of p62. mRFP-EGFP-LC3 transfection assay showed that indeed chloroquine blocked the autophagic flux in HepG2 cells. Chloroquine impaired proliferation of HepG2 cells might be due to intracellular accumulation of lipids and inhibition of energy synthesis.

Identifiants

pubmed: 35695930
doi: 10.1007/s00432-022-04074-2
pii: 10.1007/s00432-022-04074-2
pmc: PMC9587105
doi:

Substances chimiques

Chloroquine 886U3H6UFF
Hepatocyte Growth Factor 67256-21-7
Ki-67 Antigen 0
Microtubule-Associated Proteins 0
Autophagy-Related Proteins 0
Protein Kinase Inhibitors 0
Triglycerides 0
Lipids 0
Adenosine Triphosphate 8L70Q75FXE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3243-3256

Subventions

Organisme : Else Kröner-Fresenius-Stiftung
ID : Jena School for Ageing Medicine

Informations de copyright

© 2022. The Author(s).

Références

Annu Rev Genet. 2009;43:67-93
pubmed: 19653858
Autophagy. 2011 Oct;7(10):1159-72
pubmed: 21691147
Hum Mol Genet. 2013 Sep 15;22(18):3667-79
pubmed: 23669347
J Pathol. 2010 May;221(1):3-12
pubmed: 20225336
Cell Death Differ. 2013 Jan;20(1):3-11
pubmed: 22595754
Lancet Oncol. 2008 Feb;9(2):117-23
pubmed: 18221915
Curr Drug Metab. 2009 Jun;10(5):470-81
pubmed: 19689244
J Hepatol. 2019 Dec;71(6):1175-1183
pubmed: 31449860
Int J Cancer. 2012 Aug 1;131(3):548-57
pubmed: 21858812
Autophagy. 2011 Jul;7(7):727-36
pubmed: 21471734
Clin J Gastroenterol. 2012;5(4):407-12
pubmed: 24672586
Cell Mol Neurobiol. 2016 Oct;36(7):1197-208
pubmed: 26971793
Pharmacogenet Genomics. 2017 Jun;27(6):240-246
pubmed: 28362716
Cancer Res. 2006 Dec 15;66(24):11851-8
pubmed: 17178882
Genes Cancer. 2011 Apr;2(4):385-91
pubmed: 21779507
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Genes Dev. 2007 Nov 15;21(22):2861-73
pubmed: 18006683
Int J Mol Sci. 2020 May 20;21(10):
pubmed: 32443776
Nature. 2009 Apr 30;458(7242):1131-5
pubmed: 19339967
Biochem Biophys Res Commun. 2015 Apr 3;459(2):234-239
pubmed: 25712526
BMC Neurol. 2016 Sep 20;16(1):178
pubmed: 27644442
Oncol Rep. 2018 Feb;39(2):711-720
pubmed: 29207150
Nat Cell Biol. 2018 Sep;20(9):1013-1022
pubmed: 30154567
Nat Rev Mol Cell Biol. 2017 Nov;18(11):671-684
pubmed: 28852221
Case Rep Cardiol. 2017;2017:7065759
pubmed: 28536660
Autophagy. 2007 Sep-Oct;3(5):452-60
pubmed: 17534139
PLoS One. 2018 Mar 19;13(3):e0194423
pubmed: 29554128
J Hepatocell Carcinoma. 2016 Jun 17;3:9-18
pubmed: 27574587
Biosci Rep. 2020 Apr 30;40(4):
pubmed: 32285908
Cell Rep. 2019 Jul 23;28(4):1029-1040.e5
pubmed: 31340141
J Cancer. 2019 Jun 9;10(16):3789-3797
pubmed: 31333796
Cancer Invest. 2009 Mar;27(3):286-92
pubmed: 19194831
Oncol Lett. 2017 Jun;13(6):5028-5034
pubmed: 28599504
Recent Results Cancer Res. 2014;201:145-64
pubmed: 24756790
Oncol Rep. 2016 Jan;35(1):43-9
pubmed: 26530158
Curr Biol. 2018 Feb 19;28(4):R170-R185
pubmed: 29462587
J Clin Invest. 2011 Jul;121(7):2821-32
pubmed: 21633171
Int J Mol Sci. 2017 Aug 28;18(9):
pubmed: 28846632
SLAS Technol. 2017 Jun;22(3):237-244
pubmed: 28314110
Autophagy. 2018;14(8):1435-1455
pubmed: 29940786
Lancet Infect Dis. 2003 Nov;3(11):722-7
pubmed: 14592603
Bioorg Med Chem. 2006 May 1;14(9):3218-22
pubmed: 16413786
Signal Transduct Target Ther. 2020 Jun 10;5(1):87
pubmed: 32532960
World J Gastroenterol. 2018 Nov 7;24(41):4643-4651
pubmed: 30416312

Auteurs

Fengming Xu (F)

Department of General, Visceral and Vascular Surgery, Jena University Hospital, 07747, Jena, Germany.
Else Kröner Graduate School for Medical Students "JSAM", Jena University Hospital, 07747, Jena, Germany.

Hans-Michael Tautenhahn (HM)

Department of General, Visceral and Vascular Surgery, Jena University Hospital, 07747, Jena, Germany.
Else Kröner Research Schools for Physicians "AntiAge", Jena University Hospital, 07747, Jena, Germany.

Olaf Dirsch (O)

Institute of Pathology, Klinikum Chemnitz gGmbH, 09111, Chemnitz, Germany.

Uta Dahmen (U)

Department of General, Visceral and Vascular Surgery, Jena University Hospital, 07747, Jena, Germany. Uta.Dahmen@med.uni-jena.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH